#afoxolaner

FDA approves NexGard expanded label claims

August 22, 2018

Merial, part of Boehringer Ingelheim, received approval from the U.S Food and Drug Administration to expand the label claims for NexGard (afoxolaner). The flea and tick control product is now approved to prevent Borrelia burgdorferi infections as a direct result of it killing Ixodes scapularis vector ticks, commonly called black-legged, or deer, ticks. NexGard is the first and only flea and tick product to receive FDA approval for preventing infections that cause Lyme disease …
COVID-19
N.C. pug tests positive for COVID-19
Bronx Zoo tiger tests positive for COVID-19
800,000 masks donated by pharma company
N.Y. cats test positive for COVID-19
From the trenches: How life has changed since COVID-19 came into our lives